Antibodies Binding To An Intracellular Prl-1 Or Prl-3 Polypeptide


The full document isn't yet available to us from the patent office.


We provide an antibody capable of binding to an intracellular PRL-1 or PRL-3 polypeptide, in which the antibody is capable of binding to an epitope bound by an antibody 269, antibody 223 or antibody 318. Such anti-PRL antibodies may be capable of binding to intracellular PRL-1 or PRL-3. They may be suitable for use as therapies against cancer or metastasis thereof, or in clinical diagnosis to identify PRL-3 or PRL-1 positive patients.


Information currently unavailable.

CPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Dec 5, 2012
  • Application: May 3, 2008
    EP EP 12159080 A
  • Priority: May 3, 2008
    EP EP 08754007 A
  • Priority: Feb 22, 2008
    US US 6422908 P
  • Priority: May 3, 2007
    US US 92420107 P

Download Citation

Sign in to the Lens